Cargando…
MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells
Chemotherapeutic insensitivity remains a major obstacle to treating osteosarcoma effectively. Recently, increasing evidence has suggested that microRNAs (miRNAs) are involved in drug resistance. However, the effect of miR-138 on cisplatin chemoresistance in osteosarcoma has not been reported. We use...
Autores principales: | Zhu, Ziqiang, Tang, Jinshan, Wang, Jianqiang, Duan, Gang, Zhou, Lei, Zhou, Xiaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809565/ https://www.ncbi.nlm.nih.gov/pubmed/27019355 http://dx.doi.org/10.1371/journal.pone.0150026 |
Ejemplares similares
-
Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2
por: Zeng, Taohui, et al.
Publicado: (2021) -
MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma
por: Zhou, Zheng, et al.
Publicado: (2017) -
MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma
por: Zhou, Zheng, et al.
Publicado: (2021) -
The Effect of miR-138 on the Function of Follicular Helper T Cells and the Differentiation of B Cells in Osteosarcoma
por: Wang, Zhitao, et al.
Publicado: (2021) -
miR-363 acts as a tumor suppressor in osteosarcoma cells by inhibiting PDZD2
por: He, Fan, et al.
Publicado: (2019)